What's new in musculoskeletal oncology

Journal of Bone and Joint Surgery

Volumn 91, Issue 6, 2009, Pages 1546-1556

  Lewis, Valerae O ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CD51 ANTIGEN; CISPLATIN; DOXORUBICIN; GEFITINIB; IFOSFAMIDE; IMATINIB; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE ACETATE; MIGRATION INHIBITION FACTOR; MURAMYL TRIPEPTIDE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ADENOCARCINOMA; ANASTOMOSIS; ARTERY THROMBOSIS; ASPIRATION BIOPSY; BENIGN TUMOR; BONE CYST; BONE METASTASIS; BONE TISSUE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CHONDROBLASTOMA; CHONDROSARCOMA; CLINICAL TRIAL; ENDOPROSTHESIS; EVENT FREE SURVIVAL; EWING SARCOMA; EXTERNAL BEAM RADIOTHERAPY; FEMUR EPIPHYSIS; FEMUR SUBTROCHANTERIC FRACTURE; FOLLOW UP; FRACTURE NONUNION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEIOMYOSARCOMA; LIMB SALVAGE; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PIGMENTED VILLONODULAR SYNOVITIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROTEIN EXPRESSION; PSEUDARTHROSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN NECROSIS; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SURGICAL TECHNIQUE; SURVIVAL RATE; SYNOVIAL SARCOMA; TIBIA FRACTURE; TUMOR LOCALIZATION; TUMOR VOLUME; VISCOSITY; WOUND COMPLICATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BONE TUMOR; DIAGNOSTIC IMAGING; FEMALE; FORECASTING; INTERVENTIONAL RADIOLOGY; MALE; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; MUSCLE TUMOR; ONCOLOGY; RISK ASSESSMENT; STANDARD; SURGERY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LIMB SALVAGE; MALE; MEDICAL ONCOLOGY; MUSCLE NEOPLASMS; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 67649871425     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.I.00375     Document Type: Review

References (44)

1. Huang Y, Lin Z, Zhuang J, Chen Y, Lin J. Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy. Onkologie. 2008;31:535-540
2. Han I, Lee MR, Nam KW, Oh JH, Moon KC, Kim HS. Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma. Clin Orthop Relat Res. 2008;466:2107-2113
3. Kim MS, Cho WH, Song WS, Lee SY, Jeon DG. Time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res. 2007;463:157-165
4. Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Shin DS, Jeon DG. Growth patterns of osteosarcoma predict patient survival. Arch Orthop Trauma Surg. 2008 Aug 6 [Epub ahead of print].
5. Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Ann Surg Oncol. 2008;15:906-914
6. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE; Children's Oncology Group. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival - a report from the Children's Oncology Group. J Clin Oncol. 2008;26:633-638 (Pubitemid 351264359)
7. Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, Reaman GH. Osteosarcoma: the same old drugs or more? J Clin Oncol. 2008;26:3102-3105
8. Hunsberger S, Freidlin B, Smith MA. Complexities in interpretation of osteosarcoma clinical trial results. J Clin Oncol. 2008;26:3103-3105
9. Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kühne T, Maas R, Schwarz R, Zoubek A, Jürgens H. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive Cooperative Osteosarcoma Study Group patients. J Clin Oncol. 2009;27:557-565
10. Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Postoperative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887-2895
11. Lee JA, Kim MS, Kim DH, Lim JS, Park KD, Cho WH, Song WS, Lee SY, Jeon DG. Postoperative infection and survival in osteosarcoma patients. Ann Surg Oncol. 2009;16:147-151
12. Fuchs B, Hoekzema N, Larson DR, Inwards CY, Sim FH. Osteosarcoma of the pelvis: outcome analysis of surgical treatment. Clin Orthop Relat Res. 2009;467:510-518
13. Schwab JH, Antonescu CR, Athanasian EA, Boland PJ, Healey JH, Morris CD. A comparison of intramedullary and juxtacortical low-grade osteogenic sarcoma. Clin Orthop Relat Res. 2008;466:1318-1322
14. Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89:2113-2123
15. Staals EL, Bacchini P, Mercuri M, Bertoni F. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas. J Bone Joint Surg Am. 2007;89:987-993 (Pubitemid 46724588)
16. Streitbürger A, Ahrens H, Balke M, Buerger H, Winkelmann W, Gosheger G, Hardes J. Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol. 2009;135:543-550
17. Schwab JH, Wenger D, Unni K, Sim FH. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones? Clin Orthop Relat Res. 2007;462:175-180
18. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE; Children's Oncology Group. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51:334-338
19. Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol. 2008;30:425-430
20. Fleshman R, Mayerson J, Wakely PE Jr. Fine-needle aspiration biopsy of high-grade sarcoma: a report of 107 cases. Cancer. 2007;111:491-498 (Pubitemid 350304901)
21. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007;246:675-682 (Pubitemid 47480622)
22. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573-581
23. Karavasilis V, Seddon BM, Ashley S, Al-Muderis O, Fisher C, Judson I. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer. 2008;112:1585-1591
24. Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG, Schuetze SM, Baker LH. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist. 2008;13:451-458
25. Bifulco K, De Chiara A, Fazioli F, Longanesi-Cattani I, Cantelmo AR, Tirino V, Apice G, Rocco G, Lombardi ML, Carriero MV. Cell invasiveness in sarcomas: a possibly useful clinical correlation. Tumori. 2008;94:505-510
26. Martinez SR, Robbins AS, Meyers FJ, Bold RJ, Khatri VP, Goodnight JE Jr. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008;112:1162-1168
27. Christie-Large M, Evans N, Davies AM, James SL. Radiofrequency ablation of chondroblastoma: procedure technique, clinical and MR imaging follow up of four cases. Skeletal Radiol. 2008;37:1011-1017
28. Lin PP, Brown C, Raymond AK, Deavers MT, Yasko AW. Aneurysmal bone cysts recur at juxtaphyseal locations in skeletally immature patients. Clin Orthop Relat Res. 2008;466:722-728
29. Wright JG, Yandow S, Donaldson S, Marley L; Simple Bone Cyst Trial Group. A randomized clinical trial comparing intralesional bone marrow and steroid injections for simple bone cysts. J Bone Joint Surg Am. 2008;90:722-730
30. Bifulco K, De Chiara A, Fazioli F, Longanesi-Cattani I, Cantelmo AR, Tirino V, Apice G, Rocco G, Lombardi ML, Carriero MV. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007;31:970-976
31. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A. 2006;103:690-695 (Pubitemid 43153087)
32. Blay JY, El Sayadi H, Thiesse P, Garret J, Ray-Coquard I. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol. 2008;19:821-822
33. Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Maass N, Arnold N, Wessel R, Ramser J, Meindl A, Scherneck S, Seitz S. Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 2009;276:212-220
34. Ando M, Ando Y, Sugiura S, Minami H, Saka H, Sakai S, Shimokata K, Hasegawa Y. Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. Jpn J Cancer Res. 1999;90:249-253 (Pubitemid 29112327)
35. Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res. 2008;466:729-736
36. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25:1423-1436 (Pubitemid 46706892)
37. Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2008 Dec 9 [Epub ahead of print].
38. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346-350 (Pubitemid 351630250)
39. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89:349-353 (Pubitemid 46563912)
40. Delloye C, Banse X, Brichard B, Docquier PL, Cornu O. Pelvic reconstruction with a structural pelvic allograft after resection of a malignant bone tumor. J Bone Joint Surg Am. 2007;89:579-587 (Pubitemid 46365358)
41. Cartiaux O, Docquier PL, Paul L, Francq BG, Cornu OH, Delloye C, Raucent B, Dehez B, Banse X. Surgical inaccuracy of tumor resection and reconstruction within the pelvis: an experimental study. Acta Orthop. 2008;79:695-702.
42. van Kampen M, Grimer RJ, Carter SR, Tillman RM, Abudu A. Replacement of the hip in children with a tumor in the proximal part of the femur. J Bone Joint Surg Am. 2008;90:785-795
43. Sawamura C, Hornicek FJ, Gebhardt MC. Complications and risk factors for failure of rotationplasty: review of 25 patients. Clin Orthop Relat Res. 2008;466:1302-1308
44. Mahoney CR, Hartman CW, Simon PJ, Baxter BT, Neff JR. Vascular management in rotationplasty. Clin Orthop Relat Res. 2008;466:1210-1216